眼科与视觉会议摘要发展为全文发表的比例:系统综述与Meta分析
结果显示加权全文发表比例为38.0%(95%CI,31.7%-44.3%),仅限于随机临床试验摘要的报告为54.9%(95%CI,34.6%-73.7%);口头报告与基础科学摘要与更高全文发表率显著相关。
要点
- 眼科与视觉会议摘要加权全文发表比例为38.0%(95%CI,31.7%-44.3%)。
- 仅限于随机临床试验摘要的报告全文发表比例为54.9%(95%CI,34.6%-73.7%)。
- 口头报告(风险比1.45;95%CI,1.20-1.76)与基础科学(风险比1.25;95%CI,1.05-1.47)与更高全文发表显著相关。
核心结论
- 超过60%的眼科与视觉会议摘要未在会议报告后2年内全文发表。
主要发现
- 加权全文发表比例为38.0%(95%CI,31.7%-44.3%)。
- 仅限于随机临床试验摘要的报告全文发表比例为54.9%(95%CI,34.6%-73.7%)。
- 9项报告(47.4%)调查了眼科亚专科摘要的全文发表比例,范围为28.3%(眼整形:95%CI,17.2%-42.9%)至42.7%(青光眼:95%CI,34.7%-51.0%)。
- 口头报告(风险比1.45;95%CI,1.20-1.76)与基础科学(风险比1.25;95%CI,1.05-1.47)与更高全文发表显著相关。
- 阳性结果、随机临床试验与其他研究设计、多中心研究及企业资助与全文发表无显著关联。
关键数值与推荐
- 纳入标准为评估眼科与视觉会议摘要及其后24个月或更长时间在同行评审期刊全文发表比例的报告。
临床怎么用
- 提示眼科医生在引用会议摘要时需注意其后续全文发表率有限,临床决策宜优先依据经同行评审的全文发表研究。
局限性
- 检索截止至2019年1月11日。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Conference proceedings are platforms for early communication and dissemination of relevant and timely topics of interest. More than half of abstracts presented at biomedical conferences fail to be published in full, resulting in wasted time and resources. OBJECTIVE: To systematically review reports evaluating the proportion of abstracts presented at eye and vision conferences that are subsequently published in full and investigate factors associated with publication. DATA SOURCES: MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, and reference lists of included reports were systematically searched from inception to January 11, 2019. STUDY SELECTION: Reports that examined the proportion of abstracts presented at eye and vision conferences and subsequently published in peer-reviewed journals 24 or more months later. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently assessed study eligibility, abstracted data, and evaluated the risk of bias. A meta-analysis was conducted to determine the proportion of abstracts published in full and assess factors associated with subsequent full publication. MAIN OUTCOMES AND MEASURES: Proportion of abstracts presented at eye and vision conferences subsequently published in full. RESULTS: There were 19 reports covering 12 261 abstracts presented at 11 unique eye and vision conferences. The overall risk of bias of the reports was low. The weighted proportion of abstracts published in full was 38.0% (95% CI, 31.7%-44.3%) and 54.9% (95% CI, 34.6%-73.7%) among reports restricted to abstracts describing randomized clinical trials. Nine reports (47.4%) investigated the proportion of abstracts subsequently published by ophthalmic subspecialties, ranging from 28.3% (oculoplastics: 95% CI, 17.2%-42.9%) to 42.7% (glaucoma: 95% CI, 34.7%-51.0%). Oral presentation (risk ratio, 1.45; 95% CI, 1.20-1.76) and basic science (risk ratio, 1.25; 95% CI, 1.05-1.47) were significantly associated with higher full publication; factors not significantly associated with full publication included positive results, randomized clinical trial vs other study design, multicenter study, and industry funding. CONCLUSION AND RELEVANCE: More than 60% of abstracts presented at eye and vision conferences were not published in full within 2 years of conference presentation. Failure to disseminate research studies in peer-reviewed journals is not desired, especially when involving human participants.
引用
- E JY, Ramulu PY, Fapohunda K, et al. Frequency of Abstracts Presented at Eye and Vision Conferences Being Developed Into Full-Length Publications: A Systematic Review and Meta-analysis. JAMA Ophthalmol. 2020. PMID: 32352508. doi:10.1001/jamaophthalmol.2020.1264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。